# INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)

Study · id `cardio:ct-nct03539302` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03539302](<https://clinicaltrials.gov/study/NCT03539302>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03539302

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 176 participants.

## Technical summary

Registry record NCT03539302. Allocation not applicable; no masking; primary purpose treatment. Start 2018-05-29 (actual); primary completion 2022-01-17 (actual). Results posted on 2024-05-14.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 176 participants (enrolled count; ClinicalTrials.gov record NCT03539302, source copy `cardio:ctgov-nct03539302-2024-05-14`, retrieved 2026-10-26)
- Started: 2018-05-29 (actual) (ClinicalTrials.gov record NCT03539302, source copy `cardio:ctgov-nct03539302-2024-05-14`, retrieved 2026-10-26)
- Primary completion: 2022-01-17 (actual) (ClinicalTrials.gov record NCT03539302, source copy `cardio:ctgov-nct03539302-2024-05-14`, retrieved 2026-10-26)
- Completion: 2022-01-17 (actual) (ClinicalTrials.gov record NCT03539302, source copy `cardio:ctgov-nct03539302-2024-05-14`, retrieved 2026-10-26)
- Results first posted: 2024-05-14 (ClinicalTrials.gov record NCT03539302, source copy `cardio:ctgov-nct03539302-2024-05-14`, retrieved 2026-10-26)
- Countries: Belgium; Netherlands (ClinicalTrials.gov record NCT03539302, source copy `cardio:ctgov-nct03539302-2024-05-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03539302-2024-05-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT)
- Acronym: INSTANT
- Condition: Paroxysmal Atrial Fibrillation (PAF)
- Intervention (Drug): Flecainide Acetate
- Lead sponsor: InCarda Therapeutics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial (`cardio:pubmed-38613545`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 74454af2f9c63c0360716d15dcceff1203ccd8b4cf1e81ccbed3e53a18cd9431
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
